跳至主要内容
临床试验/NCT02961361
NCT02961361已完成4 期

the Effect of Dexmedetomidine in Coracoid Approach Brachial Plexus Block

The First Hospital of Qinhuangdao0 个研究点目标入组 60 人开始时间: 2016年11月12日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
60
主要终点
duration time

研究概览

简要总结

Dexmedetomidine is an α-2 adrenoreceptor agonist and has been extensively used through intravenous infusion,in order to improved the quality of block in regional anesthesia. In this prospective, randomized study, the authors focus on the effect of dexmedetomidine mixed with ropivacaine in coracoid approach brachial plexus block.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • American Society of Anesthesiologists (ASA) physical status I or II;
  • Aged 18-60 years;
  • The elbow, forearm, wrist or hand surgery

排除标准

  • History of allergy to local anesthetics;
  • Coagulation dysfunction, neuromuscular disease or local infection;
  • The operation time is longer than the local anesthetics effective time.

研究组 & 干预措施

Group Control

Experimental

40 ml 0.375% ropivacaine was injected after Locating brachial plexus.

干预措施: ropivacaine (Drug)

Group Dexmedetomidine

Experimental

40 ml 0.375% ropivacaine mixed with dexmedetomidine was injected after Locating brachial plexus.

干预措施: ropivacaine mixed with dexmedetomidine (Drug)

结局指标

主要结局

duration time

时间窗: once per hour after surgery until 24 hours after surgery

effective analgesia time

次要结局

  • onset time(5,10,15,20,25,30 min after injection)
  • Visual analogue scale(2,6,12,24hour after injection)

研究者

发起方
The First Hospital of Qinhuangdao
申办方类型
Other Gov
责任方
Sponsor

相似试验